© All rights reserved to Barnea Jaffa Lande & Co. Law offices

Together is global

Together is global

Technology / Mergers and Acquisitions

 We have an excellent track record of M&A technology transactions

Our technology department team has extensive experience in guiding and managing technology companies’ M&A transactions, from planning the structure of the transaction, conducting the negotiations, drafting of the entire set of agreements, working opposite the various government authorities and financing entities whose approvals are required in order to proceed with the transaction, to consummating and implementing the transaction.

 

Over the years, Barnea has been involved in a variety of sale transactions of Israeli technology companies in diverse sectors, including communications companies, medical instrumentation companies, hardware and software companies, internet companies and more.

 

The head of our technology department, Micky Barnea and Dr. Dotan Baruch have excellent reputations and vast experience in advising and guiding complex large-scale technology M&A transactions.

 

Micky Barnea and Dr. Dotan Baruch are considered prominent leaders in the high-tech sector by Israeli and international rating directories. 

 

Back to Technology

News and updates - Technology / Mergers and Acquisitions:


December 12, 2019

Representing Sartorius in the acquisition of a majority stake in Biological Industries.

Our firm represented Sartorius, a leading multinational corporation in the field of life science, research and development  and biopharmaceutical industry, in a transaction to acquire a majority stake in the Israeli cell culture developer Biological Industries. Sartorius acquired the majority of Biological Industries shares by way of secondary purchase of shares from the Development Company of Kibbutz Beit Haemek and private equity fund Fortissimo Capital, in consideration for USD 50 million. In addition, as part of the transaction, Sartorius and the Development Company of Kibbutz Beit Haemek signed an option to purchase/sell additional holdings in the future.

November 18, 2019

Representing Cymplify in Acquisition by Check Point

Our firm represented the IoT security company Cymplify in its acquisition by NASDAQ-listed cloud security company Check Point Software Technologies Ltd. for USD 5 million.

October 16, 2019

Representing German Fund Mercura in Investment in Israeli Startup 3DSignals

Our firm represented the German fund Mercura in its investment in 3DSignals. This Israeli startup enables the monitoring of production floor performance. The investment follows the company's rapid growth in the German market.

Technology / Mergers and Acquisitions

 We have an excellent track record of M&A technology transactions

Our technology department team has extensive experience in guiding and managing technology companies’ M&A transactions, from planning the structure of the transaction, conducting the negotiations, drafting of the entire set of agreements, working opposite the various government authorities and financing entities whose approvals are required in order to proceed with the transaction, to consummating and implementing the transaction.

 

Over the years, Barnea has been involved in a variety of sale transactions of Israeli technology companies in diverse sectors, including communications companies, medical instrumentation companies, hardware and software companies, internet companies and more.

 

The head of our technology department, Micky Barnea and Dr. Dotan Baruch have excellent reputations and vast experience in advising and guiding complex large-scale technology M&A transactions.

 

Micky Barnea and Dr. Dotan Baruch are considered prominent leaders in the high-tech sector by Israeli and international rating directories. 

 

Back to Technology

News and updates - Technology:


December 12, 2019

Representing Sartorius in the acquisition of a majority stake in Biological Industries.

Our firm represented Sartorius, a leading multinational corporation in the field of life science, research and development  and biopharmaceutical industry, in a transaction to acquire a majority stake in the Israeli cell culture developer Biological Industries. Sartorius acquired the majority of Biological Industries shares by way of secondary purchase of shares from the Development Company of Kibbutz Beit Haemek and private equity fund Fortissimo Capital, in consideration for USD 50 million. In addition, as part of the transaction, Sartorius and the Development Company of Kibbutz Beit Haemek signed an option to purchase/sell additional holdings in the future.

November 18, 2019

Representing Cymplify in Acquisition by Check Point

Our firm represented the IoT security company Cymplify in its acquisition by NASDAQ-listed cloud security company Check Point Software Technologies Ltd. for USD 5 million.

October 16, 2019

Representing German Fund Mercura in Investment in Israeli Startup 3DSignals

Our firm represented the German fund Mercura in its investment in 3DSignals. This Israeli startup enables the monitoring of production floor performance. The investment follows the company's rapid growth in the German market.

Enter your email for newsletter sign up: